MET and hepatocellular carcinoma: Zhang et al. [36] demonstrated that the inhibition of both VEGFR-2 and MET yielded a more promising effect on suppressing tumor growth and metastasis in hepatocellular carcinoma than blocking VEGFR-2 did.